Compare SKT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKT | TMDX |
|---|---|---|
| Founded | 1981 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.2B |
| IPO Year | 1993 | 2019 |
| Metric | SKT | TMDX |
|---|---|---|
| Price | $32.58 | $136.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | $36.14 | ★ $144.25 |
| AVG Volume (30 Days) | ★ 921.5K | 657.5K |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.59% | N/A |
| EPS Growth | 8.00 | ★ 170.70 |
| EPS | 0.94 | ★ 2.54 |
| Revenue | ★ $575,140,000.00 | $566,354,000.00 |
| Revenue This Year | $3.57 | $38.73 |
| Revenue Next Year | $4.70 | $20.55 |
| P/E Ratio | ★ $34.64 | $53.35 |
| Revenue Growth | 10.01 | ★ 41.20 |
| 52 Week Low | $28.69 | $58.54 |
| 52 Week High | $36.76 | $156.00 |
| Indicator | SKT | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 36.81 | 53.96 |
| Support Level | $33.30 | $132.02 |
| Resistance Level | $33.70 | $149.22 |
| Average True Range (ATR) | 0.73 | 7.66 |
| MACD | -0.15 | 0.20 |
| Stochastic Oscillator | 14.55 | 48.91 |
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.